Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFORT Extension Study (EFFORT-Ex)
NCT01529255Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Aug 2011
- Primary completion
- Aug 2015
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of telbivudine in hepatitis B (HBV), sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
telbivudine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01529255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529255.